Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Narrative Literature Review on Risk Factors Involved In Breast Cancer, Brain Cancer, Colon Rectal Cancer, Gynecological Malignancy, Lung Cancer, and Prostate Cancer

Version 1 : Received: 10 April 2021 / Approved: 13 April 2021 / Online: 13 April 2021 (10:08:01 CEST)
Version 2 : Received: 30 April 2021 / Approved: 5 May 2021 / Online: 5 May 2021 (12:04:56 CEST)

How to cite: Justiz-Vaillant, A.; Gardiner, L.; Mohammed, M.; Surajbally, M.; Maharaj, L.; Ramsingh, L.; Simon, M.; Seegobin, M.; Niles, M. Narrative Literature Review on Risk Factors Involved In Breast Cancer, Brain Cancer, Colon Rectal Cancer, Gynecological Malignancy, Lung Cancer, and Prostate Cancer . Preprints 2021, 2021040334. https://doi.org/10.20944/preprints202104.0334.v1 Justiz-Vaillant, A.; Gardiner, L.; Mohammed, M.; Surajbally, M.; Maharaj, L.; Ramsingh, L.; Simon, M.; Seegobin, M.; Niles, M. Narrative Literature Review on Risk Factors Involved In Breast Cancer, Brain Cancer, Colon Rectal Cancer, Gynecological Malignancy, Lung Cancer, and Prostate Cancer . Preprints 2021, 2021040334. https://doi.org/10.20944/preprints202104.0334.v1

Abstract

In this study, we describe the most critical risk factors for different malignancies, including breast, prostate, lung, colon-rectal carcinoma, among others and those with risk factors that are modifiable. We revised the literature review about risk factors involved in the genesis of cancer in various databases, including articles indexed in PUBMED, SCOPUS, PMC, and Google Scholar. Knowing risk factors is a mode of fighting malignancy. Diet, lifestyle, practises, and laboratory/clinical interventions were among risk factors of diverse malignancy. We conclude that risk factors can prevent the development of many malignancies in a century where this conundrum is raising disproportionably. It is treated here is to make the public aware of the modifiable risks of cancers.

Keywords

Risk factors, lifestyle, practises, breast cancer, prostate cancer, malignancy.

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.